Capricor Therapeutics CAPR
NASDAQ CAPR
$11.22 +2.35 (+26.49%)
At close: Nov 11, 2026 · 4:00 PM EST

Capricor Therapeutics (CAPR) Return on Equity [ROE] (2009 - 2026)

Updated

Capricor Therapeutics' Return on Equity [ROE] came in at -48.15% for Q2 2026, up 11.92 percentage points from -60.07% a year earlier but down 9.98 percentage points from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Capricor Therapeutics' Return on Equity [ROE] was -46.56%, up 1.60 percentage points from FY2024.

  • Return on Equity [ROE] has increased in each of the last three years, with a five-year change of +31.40 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -48.16% in FY2024 (+81.83 pp), -129.98% in FY2023 (+5.23 pp), -135.22% in FY2022 (-65.11 pp) and -70.11% in FY2021 (+7.84 pp).
  • The five-year range for quarterly Return on Equity [ROE] is -6191.10% (Q3 2023) to -37.77% (Q4 2024).
  • Year-over-year, Return on Equity [ROE] increased in six of the last eight quarters, with an average year-over-year change of +810.79 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2024 (a gain of 6105.40 percentage points), and the weakest in Q3 2023 (a drop of 6028.00 percentage points).
  • Business Quant data shows CAPR's Return on Equity [ROE] at -38.17% (Q1 2026), -52.36% (Q4 2025) and -86.72% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Capricor Therapeutics 515.69 Mn -516.56 Mn - -65.13%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -65.13%
Jun 30, 2026 -49.90%
Mar 31, 2026 -39.92%
Dec 31, 2025 -54.30%
Sep 30, 2025 -86.04%
Jun 30, 2025 -59.10%
Mar 31, 2025 -39.22%
Dec 31, 2024 -37.13%
Sep 30, 2024 -55,554,079.67%
Jun 30, 2024 -148,022,836.13%
Mar 31, 2024 -107,986,920.12%
Dec 31, 2023 -212,906,449.47%
Sep 30, 2023 -6,129,109,448.33%
Jun 30, 2023 -647,039,392.52%
Mar 31, 2023 -321,406,589.02%
Dec 31, 2022 -212,506,727.59%
Sep 30, 2022 -117,243,401.30%
Jun 30, 2022 -92,329,989.41%
Mar 31, 2022 -71,495,435.60%
Dec 31, 2021 -58,799,890.80%
API Access

Capricor Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CAPR&period=max&api_key=YOUR_API_KEY